Key result
Coadministration of PTI and tPA significantly improved tPA-induced thrombolysis in a rabbit model without adversely affecting blood pressure or coagulation parameters.
Why the study?
Does coadministration of a TAFIa inhibitor (PTI) with tPA improve thrombolysis compared to tPA alone in a rabbit arterial thrombolysis model?
Does coadministration of a TAFIa inhibitor (PTI) with tPA improve thrombolysis compared to tPA alone in a rabbit arterial thrombolysis model?
Inhibition of activated TAFI enhances tPA-induced arterial thrombolysis in a rabbit model without increasing bleeding risk markers, suggesting a novel adjunctive strategy for acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for TAFIa inhibition to enhance thrombolysis; human trials needed before clinical evaluation.
Klement et al. (1999) studied Acute myocardial infarction / arterial thrombosis. Potato tuber inhibitor (PTI) of activated TAFI plus tPA vs. tPA alone was evaluated on Thrombolytic efficacy (time to patency, time patent, maximal blood flow, clot lysis percentage). Coadministration of PTI and tPA significantly improved tPA-induced thrombolysis in a rabbit model without adversely affecting blood pressure or coagulation parameters.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: